RBM45 Modulates the Antioxidant Response in Amyotrophic Lateral Sclerosis through Interactions with KEAP1

REFERENCES

• Kiernan MC, Vucic S, Cheah BC, Turner MR, Eisen A, Hardiman O, Burrell JR, Zoing MC. 2011. Amyotrophic lateral sclerosis. Lancet 377:942–955. http://dx.doi.org/10.1016/S0140-6736(10)61156-7.
   PubMed Web of Science ®Google Scholar
• Pratt AJ, Getzoff ED, Perry JJ. 2012. Amyotrophic lateral sclerosis: update and new developments. Degener Neurol Neuromuscul Dis 2012:1–14. http://dx.doi.org/10.2147/DNND.S19803.
   PubMedGoogle Scholar
• Byrne S, Walsh C, Lynch C, Bede P, Elamin M, Kenna K, McLaughlin R, Hardiman O. 2011. Rate of familial amyotrophic lateral sclerosis: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry 82:623–627. http://dx.doi.org/10.1136/jnnp.2010.224501.
   PubMed Web of Science ®Google Scholar
• Leigh PN, Whitwell H, Garofalo O, Buller J, Swash M, Martin JE, Gallo J-M, Weller RO, Anderton BH. 1991. Ubiquitin-immunoreactive intraneuronal inclusions in amyotrophic lateral sclerosis; morphology, distribution and specificity. Brain 114:775–788. http://dx.doi.org/10.1093/brain/114.2.775.
   PubMed Web of Science ®Google Scholar
• Turner MR, Bowser R, Bruijn L, Dupuis L, Ludolph A, McGrath M, Manfredi G, Maragakis N, Miller RG, Pullman SL, Rutkove SB, Shaw PJ, Shefner J, Fischbeck KH. 2013. Mechanisms, models and biomarkers in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener 14(Suppl 1):19–32. http://dx.doi.org/10.3109/21678421.2013.778554.
   PubMed Web of Science ®Google Scholar
• Lagier-Tourenne C, Polymenidou M, Cleveland DW. 2010. TDP-43 and FUS/TLS: emerging roles in RNA processing and neurodegeneration. Hum Mol Genet 19:R46–R64. http://dx.doi.org/10.1093/hmg/ddq137.
   PubMed Web of Science ®Google Scholar
• Verma A, Tandan R. 2013. RNA quality control and protein aggregates in amyotrophic lateral sclerosis: a review. Muscle Nerve 47:330–338. http://dx.doi.org/10.1002/mus.23673.
   PubMedGoogle Scholar
• Li YR, King OD, Shorter J, Gitler AD. 2013. Stress granules as crucibles of ALS pathogenesis. J Cell Biol 201:361–372. http://dx.doi.org/10.1083/jcb.201302044.
   PubMed Web of Science ®Google Scholar
• Collins M, Riascos D, Kovalik T, An J, Krupa K, Hood BL, Conrads TP, Renton AE, Traynor BJ, Bowser R. 2012. The RNA-binding motif 45 (RBM45) protein accumulates in inclusion bodies in amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration with TDP-43 inclusions (FTLD-TDP) patients. Acta Neuropathol 124:717–732. http://dx.doi.org/10.1007/s00401-012-1045-x.
   PubMed Web of Science ®Google Scholar
• Tamada H, Sakashita E, Shimazaki K, Ueno E, Hamamoto T, Kagawa Y, Endo H. 2002. cDNA cloning and characterization of Drb1, a new member of RRM-type neural RNA-binding protein. Biochem Biophys Res Commun 297:96–104. http://dx.doi.org/10.1016/S0006-291X(02)02132-0.
   PubMed Web of Science ®Google Scholar
• Hans F, Fiesel FC, Strong JC, Jackel S, Rasse TM, Geisler S, Springer W, Schulz JB, Voigt A, Kahle PJ. 2014. UBE2E ubiquitin-conjugating enzymes and ubiquitin isopeptidase Y regulate TDP-43 protein ubiquitination. J Biol Chem 289:19164–19179. http://dx.doi.org/10.1074/jbc.M114.561704.
   PubMed Web of Science ®Google Scholar
• Halliwell B. 2006. Oxidative stress and neurodegeneration: where are we now? J Neurochem 97:1634–1658. http://dx.doi.org/10.1111/j.1471-4159.2006.03907.x.
   PubMed Web of Science ®Google Scholar
• Aguirre N, Beal MF, Matson WR, Bogdanov MB. 2005. Increased oxidative damage to DNA in an animal model of amyotrophic lateral sclerosis. Free Radic Res 39:383–388. http://dx.doi.org/10.1080/10715760400027979.
   PubMed Web of Science ®Google Scholar
• Andrus PK, Fleck TJ, Gurney ME, Hall ED. 1998. Protein oxidative damage in a transgenic mouse model of familial amyotrophic lateral sclerosis. J Neurochem 71:2041–2048.
   PubMed Web of Science ®Google Scholar
• Ferrante RJ, Shinobu LA, Schulz JB, Matthews RT, Thomas CE, Kowall NW, Gurney ME, Beal MF. 1997. Increased 3-nitrotyrosine and oxidative damage in mice with a human copper/zinc superoxide dismutase mutation. Ann Neurol 42:326–334. http://dx.doi.org/10.1002/ana.410420309.
   PubMed Web of Science ®Google Scholar
• Miana-Mena FJ, Gonzalez-Mingot C, Larrode P, Munoz MJ, Olivan S, Fuentes-Broto L, Martinez-Ballarin E, Reiter RJ, Osta R, Garcia JJ. 2011. Monitoring systemic oxidative stress in an animal model of amyotrophic lateral sclerosis. J Neurol 258:762–769. http://dx.doi.org/10.1007/s00415-010-5825-8.
   PubMedGoogle Scholar
• Nikolic-Kokic A, Stevic Z, Blagojevic D, Davidovic B, Jones DR, Spasic MB. 2006. Alterations in anti-oxidative defence enzymes in erythrocytes from sporadic amyotrophic lateral sclerosis (SALS) and familial ALS patients. Clin Chem Lab Med 44:589–593. http://dx.doi.org/10.1515/CCLM.2006.111.
   PubMed Web of Science ®Google Scholar
• Simpson EP, Henry YK, Henkel JS, Smith RG, Appel SH. 2004. Increased lipid peroxidation in sera of ALS patients: a potential biomarker of disease burden. Neurology 62:1758–1765. http://dx.doi.org/10.1212/WNL.62.10.1758.
   PubMed Web of Science ®Google Scholar
• Ferrante RJ, Browne SE, Shinobu LA, Bowling AC, Baik MJ, MacGarvey U, Kowall NW, Brown RH, Jr, Beal MF. 1997. Evidence of increased oxidative damage in both sporadic and familial amyotrophic lateral sclerosis. J Neurochem 69:2064–2074.
   PubMed Web of Science ®Google Scholar
• D'Amico E, Factor-Litvak P, Santella RM, Mitsumoto H. 2013. Clinical perspective of oxidative stress in sporadic ALS. Free Radic Biol Med 65:509–527. http://dx.doi.org/10.1016/j.freeradbiomed.2013.06.029.
   PubMed Web of Science ®Google Scholar
• Zhang DD. 2006. Mechanistic studies of the Nrf2-Keap1 signaling pathway. Drug Metab Rev 38:769–789. http://dx.doi.org/10.1080/03602530600971974.
   PubMed Web of Science ®Google Scholar
• Taguchi K, Motohashi H, Yamamoto M. 2011. Molecular mechanisms of the Keap1-Nrf2 pathway in stress response and cancer evolution. Genes Cells 16:123–140. http://dx.doi.org/10.1111/j.1365-2443.2010.01473.x.
   PubMed Web of Science ®Google Scholar
• Tong KI, Kobayashi A, Katsuoka F, Yamamoto M. 2006. Two-site substrate recognition model for the Keap1-Nrf2 system: a hinge and latch mechanism. Biol Chem 387:1311–1320. http://dx.doi.org/10.1515/BC.2006.164.
   PubMed Web of Science ®Google Scholar
• Komatsu M, Kurokawa H, Waguri S, Taguchi K, Kobayashi A, Ichimura Y, Sou YS, Ueno I, Sakamoto A, Tong KI, Kim M, Nishito Y, Iemura S, Natsume T, Ueno T, Kominami E, Motohashi H, Tanaka K, Yamamoto M. 2010. The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1. Nat Cell Biol 12:213–223. http://dx.doi.org/10.1038/ncb2021.
   PubMed Web of Science ®Google Scholar
• Chorley BN, Campbell MR, Wang X, Karaca M, Sambandan D, Bangura F, Xue P, Pi J, Kleeberger SR, Bell DA. 2012. Identification of novel NRF2-regulated genes by ChIP-Seq: influence on retinoid X receptor alpha. Nucleic Acids Res 40:7416–7429. http://dx.doi.org/10.1093/nar/gks409.
   PubMed Web of Science ®Google Scholar
• Mimoto T, Miyazaki K, Morimoto N, Kurata T, Satoh K, Ikeda Y, Abe K. 2012. Impaired antioxydative Keap1/Nrf2 system and the downstream stress protein responses in the motor neuron of ALS model mice. Brain Res 1446:109–118. http://dx.doi.org/10.1016/j.brainres.2011.12.064.
   PubMed Web of Science ®Google Scholar
• Kraft AD, Resch JM, Johnson DA, Johnson JA. 2007. Activation of the Nrf2-ARE pathway in muscle and spinal cord during ALS-like pathology in mice expressing mutant SOD1. Exp Neurol 207:107–117. http://dx.doi.org/10.1016/j.expneurol.2007.05.026.
   PubMed Web of Science ®Google Scholar
• Guo Y, Zhang Y, Wen D, Duan W, An T, Shi P, Wang J, Li Z, Chen X, Li C. 2013. The modest impact of transcription factor Nrf2 on the course of disease in an ALS animal model. Lab Invest 93:825–833. http://dx.doi.org/10.1038/labinvest.2013.73.
   PubMed Web of Science ®Google Scholar
• Vargas MR, Burton NC, Kutzke J, Gan L, Johnson DA, Schafer M, Werner S, Johnson JA. 2013. Absence of Nrf2 or its selective overexpression in neurons and muscle does not affect survival in ALS-linked mutant hSOD1 mouse models. PLoS One 8:e56625. http://dx.doi.org/10.1371/journal.pone.0056625.
   PubMed Web of Science ®Google Scholar
• Vargas MR, Johnson DA, Sirkis DW, Messing A, Johnson JA. 2008. Nrf2 activation in astrocytes protects against neurodegeneration in mouse models of familial amyotrophic lateral sclerosis. J Neurosci 28:13574–13581. http://dx.doi.org/10.1523/JNEUROSCI.4099-08.2008.
   PubMed Web of Science ®Google Scholar
• Sarlette A, Krampfl K, Grothe C, Neuhoff N, Dengler R, Petri S. 2008. Nuclear erythroid 2-related factor 2-antioxidative response element signaling pathway in motor cortex and spinal cord in amyotrophic lateral sclerosis. J Neuropathol Exp Neurol 67:1055–1062. http://dx.doi.org/10.1097/NEN.0b013e31818b4906.
   PubMed Web of Science ®Google Scholar
• Tanji K, Maruyama A, Odagiri S, Mori F, Itoh K, Kakita A, Takahashi H, Wakabayashi K. 2013. Keap1 is localized in neuronal and glial cytoplasmic inclusions in various neurodegenerative diseases. J Neuropathol Exp Neurol 72:18–28. http://dx.doi.org/10.1097/NEN.0b013e31827b5713.
   PubMedGoogle Scholar
• Guo Y, Wang Q, Zhang K, An T, Shi P, Li Z, Duan W, Li C. 2012. HO-1 induction in motor cortex and intestinal dysfunction in TDP-43 A315T transgenic mice. Brain Res 1460:88–95. http://dx.doi.org/10.1016/j.brainres.2012.04.003.
   PubMed Web of Science ®Google Scholar
• Duan W, Li X, Shi J, Guo Y, Li Z, Li C. 2010. Mutant TAR DNA-binding protein-43 induces oxidative injury in motor neuron-like cell. Neuroscience 169:1621–1629. http://dx.doi.org/10.1016/j.neuroscience.2010.06.018.
   PubMed Web of Science ®Google Scholar
• Furukawa M, Xiong Y. 2005. BTB protein Keap1 targets antioxidant transcription factor Nrf2 for ubiquitination by the Cullin 3-Roc1 ligase. Mol Cell Biol 25:162–171. http://dx.doi.org/10.1128/MCB.25.1.162-171.2005.
   PubMed Web of Science ®Google Scholar
• Kolarcik C, Bowser R. 2012. Retinoid signaling alterations in amyotrophic lateral sclerosis. Am J Neurodegener Dis 1:130–145.
   PubMedGoogle Scholar
• Graber DJ, Harris BT. 2013. Purification and culture of spinal motor neurons from rat embryos. Cold Spring Harb Protoc 2013:319–326. http://dx.doi.org/10.1101/pdb.prot074161.
   PubMedGoogle Scholar
• Ponti A, Schwarb P, Gulati A, Bäcker V. 2007. Huygens Remote Manager, a Web interface for high-volume batch deconvolution. Imaging Microsc 9:57–58. http://dx.doi.org/10.1002/imic.200790154.
   Google Scholar
• Parker SJ, Meyerowitz J, James JL, Liddell JR, Crouch PJ, Kanninen KM, White AR. 2012. Endogenous TDP-43 localized to stress granules can subsequently form protein aggregates. Neurochem Int 60:415–424. http://dx.doi.org/10.1016/j.neuint.2012.01.019.
   PubMedGoogle Scholar
• Mazan-Mamczarz K, Lal A, Martindale JL, Kawai T, Gorospe M. 2006. Translational repression by RNA-binding protein TIAR. Mol Cell Biol 26:2716–2727. http://dx.doi.org/10.1128/MCB.26.7.2716-2727.2006.
   PubMed Web of Science ®Google Scholar
• Taupin JL, Tian Q, Kedersha N, Robertson M, Anderson P. 1995. The RNA-binding protein TIAR is translocated from the nucleus to the cytoplasm during Fas-mediated apoptotic cell death. Proc Natl Acad Sci U S A 92:1629–1633. http://dx.doi.org/10.1073/pnas.92.5.1629.
   PubMedGoogle Scholar
• Seibenhener ML, Babu JR, Geetha T, Wong HC, Krishna NR, Wooten MW. 2004. Sequestosome 1/p62 is a polyubiquitin chain binding protein involved in ubiquitin proteasome degradation. Mol Cell Biol 24:8055–8068. http://dx.doi.org/10.1128/MCB.24.18.8055-8068.2004.
   PubMed Web of Science ®Google Scholar
• Fecto F, Yan J, Vemula SP, Liu E, Yang Y, Chen W, Zheng JG, Shi Y, Siddique N, Arrat H, Donkervoort S, Ajroud-Driss S, Sufit RL, Heller SL, Deng HX, Siddique T. 2011. SQSTM1 mutations in familial and sporadic amyotrophic lateral sclerosis. Arch Neurol 68:1440–1446. http://dx.doi.org/10.1001/archneurol.2011.250.
   PubMed Web of Science ®Google Scholar
• Teyssou E, Takeda T, Lebon V, Boillee S, Doukoure B, Bataillon G, Sazdovitch V, Cazeneuve C, Meininger V, LeGuern E, Salachas F, Seilhean D, Millecamps S. 2013. Mutations in SQSTM1 encoding p62 in amyotrophic lateral sclerosis: genetics and neuropathology. Acta Neuropathol 125:511–522. http://dx.doi.org/10.1007/s00401-013-1090-0.
   PubMed Web of Science ®Google Scholar
• Gal J, Strom AL, Kilty R, Zhang F, Zhu H. 2007. p62 accumulates and enhances aggregate formation in model systems of familial amyotrophic lateral sclerosis. J Biol Chem 282:11068–11077. http://dx.doi.org/10.1074/jbc.M608787200.
   PubMed Web of Science ®Google Scholar
• Mizuno Y, Amari M, Takatama M, Aizawa H, Mihara B, Okamoto K. 2006. Immunoreactivities of p62, an ubiquitin-binding protein, in the spinal anterior horn cells of patients with amyotrophic lateral sclerosis. J Neurol Sci 249:13–18. http://dx.doi.org/10.1016/j.jns.2006.05.060.
   PubMed Web of Science ®Google Scholar
• Sowa ME, Bennett EJ, Gygi SP, Harper JW. 2009. Defining the human deubiquitinating enzyme interaction landscape. Cell 138:389–403. http://dx.doi.org/10.1016/j.cell.2009.04.042.
   PubMed Web of Science ®Google Scholar
• Zhang DD, Lo SC, Sun Z, Habib GM, Lieberman MW, Hannink M. 2005. Ubiquitination of Keap1, a BTB-Kelch substrate adaptor protein for Cul3, targets Keap1 for degradation by a proteasome-independent pathway. J Biol Chem 280:30091–30099. http://dx.doi.org/10.1074/jbc.M501279200.
   PubMed Web of Science ®Google Scholar
• Barber SC, Shaw PJ. 2010. Oxidative stress in ALS: key role in motor neuron injury and therapeutic target. Free Radic Biol Med 48:629–641. http://dx.doi.org/10.1016/j.freeradbiomed.2009.11.018.
   PubMed Web of Science ®Google Scholar
• Parakh S, Spencer DM, Halloran MA, Soo KY, Atkin JD. 2013. Redox regulation in amyotrophic lateral sclerosis. Oxid Med Cell Longev 2013:408681. http://dx.doi.org/10.1155/2013/408681.
   PubMed Web of Science ®Google Scholar
• Cho HY. 2013. Genomic structure and variation of nuclear factor (erythroid-derived 2)-like 2. Oxid Med Cell Longev 2013:286524. http://dx.doi.org/10.1155/2013/286524.
   PubMed Web of Science ®Google Scholar
• LoGerfo A, Chico L, Borgia L, Petrozzi L, Rocchi A, D'Amelio A, Carlesi C, Caldarazzo Ienco E, Mancuso M, Siciliano G. 2014. Lack of association between nuclear factor erythroid-derived 2-like 2 promoter gene polymorphisms and oxidative stress biomarkers in amyotrophic lateral sclerosis patients. Oxid Med Cell Longev 2014:432626. http://dx.doi.org/10.1155/2014/432626.
   PubMed Web of Science ®Google Scholar
• von Otter M, Landgren S, Nilsson S, Celojevic D, Bergstrom P, Hakansson A, Nissbrandt H, Drozdzik M, Bialecka M, Kurzawski M, Blennow K, Nilsson M, Hammarsten O, Zetterberg H. 2010. Association of Nrf2-encoding NFE2L2 haplotypes with Parkinson's disease. BMC Med Genet 11:36. http://dx.doi.org/10.1186/1471-2350-11-36.
   PubMed Web of Science ®Google Scholar
• von Otter M, Landgren S, Nilsson S, Zetterberg M, Celojevic D, Bergstrom P, Minthon L, Bogdanovic N, Andreasen N, Gustafson DR, Skoog I, Wallin A, Tasa G, Blennow K, Nilsson M, Hammarsten O, Zetterberg H. 2010. Nrf2-encoding NFE2L2 haplotypes influence disease progression but not risk in Alzheimer's disease and age-related cataract. Mech Ageing Dev 131:105–110. http://dx.doi.org/10.1016/j.mad.2009.12.007.
   PubMedGoogle Scholar
• Bergstrom P, von Otter M, Nilsson S, Nilsson AC, Nilsson M, Andersen PM, Hammarsten O, Zetterberg H. 2013. Association of NFE2L2 and KEAP1 haplotypes with amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener 15:130–137. http://dx.doi.org/10.3109/21678421.2013.839708.
   PubMedGoogle Scholar
• Barber SC, Mead RJ, Shaw PJ. 2006. Oxidative stress in ALS: a mechanism of neurodegeneration and a therapeutic target. Biochim Biophys Acta 1762:1051–1067. http://dx.doi.org/10.1016/j.bbadis.2006.03.008.
   PubMed Web of Science ®Google Scholar
• Orrell RW, Lane RJ, Ross M. 2007. Antioxidant treatment for amyotrophic lateral sclerosis/motor neuron disease. Cochrane Database Syst Rev 2007:CD002829. http://dx.doi.org/10.1002/14651858.CD002829.pub4.
   PubMedGoogle Scholar
• Nanou A, Higginbottom A, Valori CF, Wyles M, Ning K, Shaw P, Azzouz M. 2013. Viral delivery of antioxidant genes as a therapeutic strategy in experimental models of amyotrophic lateral sclerosis. Mol Ther 21:1486–1496. http://dx.doi.org/10.1038/mt.2013.115.
   PubMed Web of Science ®Google Scholar
• Mead RJ, Higginbottom A, Allen SP, Kirby J, Bennett E, Barber SC, Heath PR, Coluccia A, Patel N, Gardner I, Brancale A, Grierson AJ, Shaw PJ. 2013. S[+] Apomorphine is a CNS penetrating activator of the Nrf2-ARE pathway with activity in mouse and patient fibroblast models of amyotrophic lateral sclerosis. Free Radic Biol Med 61:438–452. http://dx.doi.org/10.1016/j.freeradbiomed.2013.04.018.
   PubMed Web of Science ®Google Scholar
• Colombrita C, Zennaro E, Fallini C, Weber M, Sommacal A, Buratti E, Silani V, Ratti A. 2009. TDP-43 is recruited to stress granules in conditions of oxidative insult. J Neurochem 111:1051–1061. http://dx.doi.org/10.1111/j.1471-4159.2009.06383.x.
   PubMed Web of Science ®Google Scholar
• Meyerowitz J, Parker SJ, Vella LJ, Ng D, Price KA, Liddell JR, Caragounis A, Li QX, Masters CL, Nonaka T, Hasegawa M, Bogoyevitch MA, Kanninen KM, Crouch PJ, White AR. 2011. C-Jun N-terminal kinase controls TDP-43 accumulation in stress granules induced by oxidative stress. Mol Neurodegener 6:57. http://dx.doi.org/10.1186/1750-1326-6-57.
   PubMed Web of Science ®Google Scholar
• Yamaguchi A, Kitajo K. 2012. The effect of PRMT1-mediated arginine methylation on the subcellular localization, stress granules, and detergent-insoluble aggregates of FUS/TLS. PLoS One 7:e49267. http://dx.doi.org/10.1371/journal.pone.0049267.
   PubMedGoogle Scholar
• Neumann M, Sampathu DM, Kwong LK, Truax AC, Miscenyi MC, Chou LT, Bruce J, Schuck T, Grossman M, Clark CM, McCluskey LF, Miller BL, Masliah E, Mackenzie IR, Feldman H, Feiden W, Kretzschmar HA, Trojanowski JQ, Lee VM. 2006. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314:130–133. http://dx.doi.org/10.1126/science.1134108.
   PubMed Web of Science ®Google Scholar